Value of percutaneous transhepatic choledochoscopic lithotripsy in treatment of recurrent type <b>Ⅱ</b>a hepatolithiasis_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

TAN Dengbing ¹ , CHENG Yao ² , GONG Jianping ² ,  PENG Zili ¹

1. Department of General Surgery, Fengjie Branch, The Second Affiliated Hospital of Chongqing Medical University/Fengjie People’s Hospital, Fengjie, Chongqing 404600, P. R. China;
2. Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P. R. China;

Corresponding?author：

PENG Zili, Email: pengzili_2020@sina.com

Keywords：

percutaneous transhepatic choledochoscopic lithotripsy; hepatolithiasis; diffuse hepatolithiasis

DOI：

10.7507/1007-9424.202002086

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the feasibility and safety of percutaneous transhepatic choledochoscopic lithotripsy (PTCSL) in the treatment of recurrent type Ⅱa hepatolithiasis.Methods All of 293 patients with recurrent type Ⅱa hepatolithiasis admitted to the Second Affiliated Hospital of Chongqing Medical University from December 2010 to December 2017 were collected retrospectively, 82 of whom were treated with the PTCSL (PTCSL group), 211 of whom were treated with traditional open surgery (open group). The patients were matched according to the ratio of 1∶1 by using the method of propensity score matching, then the patients were compared after matching.Results A total of 59 pairs were successfully matched, that was, there were 59 patients in the PTCSL group and open group, respectively. Compared with the open group, the PTCSL group had the similar conditions such as the gender, age, preoperative Child-Pugh classification, and times of previous biliary operations, etc. (P>0.050). There was no perioperative death in both groups. There were no significant differences between the two groups in the success rate, operation time, times of operations, time of T tube removal after operation, stone residual rate, and stone recurrence rate (P>0.050). Although the hospital costs of the PTCSL group was higher than that of the open group (P<0.050), the PTCSL group had various advantages, such as less intraoperative bleeding, smaller incisional scar, shorter hospital stay and postoperative ventilation time, and lower rate of total postoperative complications (P<0.050).Conclusions After learning curve, PTCSL has many advantages over traditional open surgery in treatment of recurrent type Ⅱa hepatolithiasis. PTCSL is a minimally invasive surgery, which is safe and effective.

Citation： TAN Dengbing, CHENG Yao, GONG Jianping, PENG Zili. Value of percutaneous transhepatic choledochoscopic lithotripsy in treatment of recurrent type Ⅱa hepatolithiasis. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2020, 27(11): 1380-1384. doi: 10.7507/1007-9424.202002086 Copy

1.	中華醫學會外科學分會膽道外科學組. 肝膽管結石病診斷治療指南. 中華消化外科雜志, 2007, 6(2): 156-161.
2.	程南生, 李富宇, 程瑤. 肝膽管結石的外科治療現狀及展望. 中國普外基礎與臨床雜志, 2014, 21(10): 1185-1188.
3.	Chen S, Huang L, Qiu FN, et al. Total laparoscopic partial hepatectomy versus open partial hepatectomy for primary left-sided hepatolithiasis: A propensity, long-term follow-up analysis at a single center. Surgery, 2018, 163(4): 714-720.
4.	Wang Y, Bo X, Wang Y, et al. Laparoscopic surgery for choledocholithiasis concomitant with calculus of the left intrahepatic duct or abdominal adhesions. Surg Endosc, 2017, 31(11): 4780-4789.
5.	Suzuki Y, Mori T, Yokoyama M, et al. A proposed severity classification system for hepatolithiasis based on an analysis of prognostic factors in a Japanese patient cohort. J Gastroenterol, 2018, 53(7): 854-860.
6.	Lamanna A, Maingard J, Bates D, et al. Percutaneous transhepatic laser lithotripsy for intrahepatic cholelithiasis: A technical report. J Med Imaging Radiat Oncol, 2019, 63(6): 758-764.
7.	Franzini T, Cardarelli-Leite L, Figueira ERR, et al. SpyGlass percutaneous transhepatic cholangioscopy-guided lithotripsy of a large intrahepatic stone. Endoscopy, 2017, 49(12): E292-E293.
8.	Cannavale A, Bezzi M, Cereatti F, et al. Combined radiological-endoscopic management of difficult bile duct stones: 18-year single center experience. Therap Adv Gastroenterol, 2015, 8(6): 340-351.
9.	Ogura T, Higuchi K. A review of treatment options for bile duct stones. Expert Rev Gastroenterol Hepatol, 2016, 10(11): 1271-1278.
10.	Takada T, Suzuki S, Nakamura M, et al. Percutaneous transhepatic cholangioscopy as a new approach to the diagnosis of the biliary diseases. Gastroenterol Endosc, 1974, 16(1): 106-111.
11.	Zhang QL, Fujita R, Satake Y. Laser-beam lithotripsy for bile duct stone via percutaneous-transhepatic cholangioscopy. Chin Med J (Engl), 1985, 98(9): 638-642.
12.	Tao H, Wang P, Sun B, et al. One-step multichannel percutaneous transhepatic cholangioscopic lithotripsy applied in bilateral hepatolithiasis. World J Surg, 2020, 44(5): 1586-1594.
13.	Alabraba E, Travis S, Beckingham I. Percutaneous transhepatic cholangioscopy and lithotripsy in treating difficult biliary ductal stones: Two case reports. World J Gastrointest Endosc, 2019, 11(4): 298-307.
14.	劉新文, 程瑤, 龔建平. 經皮經肝膽道鏡碎石取石術治療肝膽管結石的價值. 臨床肝膽病雜志, 2019, 35(7): 1640-1643.
15.	Tazuma S. Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol, 2006, 20(6): 1075-1083.
16.	Wang P, Sun B, Huang B, et al. Comparison between percutaneous transhepatic rigid cholangioscopic lithotripsy and conventional percutaneous transhepatic cholangioscopic surgery for hepatolithiasis treatment. Surg Laparosc Endosc Percutan Tech, 2016, 26(1): 54-59.
17.	韓志敏, 盛銀行, 張風奎. 經皮肝膽道鏡術兩種不同路徑治療復雜肝內外膽管結石的臨床療效比較. 肝膽外科雜志, 2016, 24(6): 422-425.
18.	劉曉洋, 劉曉明, 智緒亭. 兩種不同 PTCSL 路徑治療肝膽管結石的臨床效果比較. 中國現代普通外科進展, 2015, 18(7): 530-532.
19.	Jeng KS, Sheen IS, Yang FS. Vascular complications in percutaneous transhepatic management of complicated hepatolithiasis with difficult intrahepatic biliary strictures: are they avoidable? Surg Laparosc Endosc Percutan Tech, 2002, 12(2): 82-87.
20.	Oh HC, Lee SK, Lee TY, et al. Analysis of percutaneous transhepatic cholangioscopy-related complications and the risk factors for those complications. Endoscopy, 2007, 39(8): 731-736.
21.	何煉圖, 湯慶, 陳綺璐, 等. 超聲引導在經皮肝膽道鏡治療肝膽管結石中的應用. 中華生物醫學工程雜志, 2015, 21(1): 81-83.

1. 中華醫學會外科學分會膽道外科學組. 肝膽管結石病診斷治療指南. 中華消化外科雜志, 2007, 6(2): 156-161.
2. 程南生, 李富宇, 程瑤. 肝膽管結石的外科治療現狀及展望. 中國普外基礎與臨床雜志, 2014, 21(10): 1185-1188.
3. Chen S, Huang L, Qiu FN, et al. Total laparoscopic partial hepatectomy versus open partial hepatectomy for primary left-sided hepatolithiasis: A propensity, long-term follow-up analysis at a single center. Surgery, 2018, 163(4): 714-720.
4. Wang Y, Bo X, Wang Y, et al. Laparoscopic surgery for choledocholithiasis concomitant with calculus of the left intrahepatic duct or abdominal adhesions. Surg Endosc, 2017, 31(11): 4780-4789.
5. Suzuki Y, Mori T, Yokoyama M, et al. A proposed severity classification system for hepatolithiasis based on an analysis of prognostic factors in a Japanese patient cohort. J Gastroenterol, 2018, 53(7): 854-860.
6. Lamanna A, Maingard J, Bates D, et al. Percutaneous transhepatic laser lithotripsy for intrahepatic cholelithiasis: A technical report. J Med Imaging Radiat Oncol, 2019, 63(6): 758-764.
7. Franzini T, Cardarelli-Leite L, Figueira ERR, et al. SpyGlass percutaneous transhepatic cholangioscopy-guided lithotripsy of a large intrahepatic stone. Endoscopy, 2017, 49(12): E292-E293.
8. Cannavale A, Bezzi M, Cereatti F, et al. Combined radiological-endoscopic management of difficult bile duct stones: 18-year single center experience. Therap Adv Gastroenterol, 2015, 8(6): 340-351.
9. Ogura T, Higuchi K. A review of treatment options for bile duct stones. Expert Rev Gastroenterol Hepatol, 2016, 10(11): 1271-1278.
10. Takada T, Suzuki S, Nakamura M, et al. Percutaneous transhepatic cholangioscopy as a new approach to the diagnosis of the biliary diseases. Gastroenterol Endosc, 1974, 16(1): 106-111.
11. Zhang QL, Fujita R, Satake Y. Laser-beam lithotripsy for bile duct stone via percutaneous-transhepatic cholangioscopy. Chin Med J (Engl), 1985, 98(9): 638-642.
12. Tao H, Wang P, Sun B, et al. One-step multichannel percutaneous transhepatic cholangioscopic lithotripsy applied in bilateral hepatolithiasis. World J Surg, 2020, 44(5): 1586-1594.
13. Alabraba E, Travis S, Beckingham I. Percutaneous transhepatic cholangioscopy and lithotripsy in treating difficult biliary ductal stones: Two case reports. World J Gastrointest Endosc, 2019, 11(4): 298-307.
14. 劉新文, 程瑤, 龔建平. 經皮經肝膽道鏡碎石取石術治療肝膽管結石的價值. 臨床肝膽病雜志, 2019, 35(7): 1640-1643.
15. Tazuma S. Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol, 2006, 20(6): 1075-1083.
16. Wang P, Sun B, Huang B, et al. Comparison between percutaneous transhepatic rigid cholangioscopic lithotripsy and conventional percutaneous transhepatic cholangioscopic surgery for hepatolithiasis treatment. Surg Laparosc Endosc Percutan Tech, 2016, 26(1): 54-59.
17. 韓志敏, 盛銀行, 張風奎. 經皮肝膽道鏡術兩種不同路徑治療復雜肝內外膽管結石的臨床療效比較. 肝膽外科雜志, 2016, 24(6): 422-425.
18. 劉曉洋, 劉曉明, 智緒亭. 兩種不同 PTCSL 路徑治療肝膽管結石的臨床效果比較. 中國現代普通外科進展, 2015, 18(7): 530-532.
19. Jeng KS, Sheen IS, Yang FS. Vascular complications in percutaneous transhepatic management of complicated hepatolithiasis with difficult intrahepatic biliary strictures: are they avoidable? Surg Laparosc Endosc Percutan Tech, 2002, 12(2): 82-87.
20. Oh HC, Lee SK, Lee TY, et al. Analysis of percutaneous transhepatic cholangioscopy-related complications and the risk factors for those complications. Endoscopy, 2007, 39(8): 731-736.
21. 何煉圖, 湯慶, 陳綺璐, 等. 超聲引導在經皮肝膽道鏡治療肝膽管結石中的應用. 中華生物醫學工程雜志, 2015, 21(1): 81-83.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Value of percutaneous transhepatic choledochoscopic lithotripsy in treatment of recurrent type Ⅱa hepatolithiasis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content